Pfizer Gets OK On Drug For Rare Lung Disorder By: Benzinga via Benzinga May 29, 2015 at 06:52 AM EDT Pfizer Inc. (NYSE: PFE) obtained regulatory approval Thursday to use its Rapamune drug as a treatment for a rare and often fatal lung ... Read More >> Related Stocks: Dr. Reddy's Laboratories Ltd ADR Pfizer